Complement C1QC as a potential prognostic marker and therapeutic target in colon carcinoma based on single-cell RNA sequencing and immunohistochemical analysis. Biomol Biomed [Internet]. 2022 Oct. 23 [cited 2024 Apr. 30];22(6):912-2. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/7309